Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Opus Genetics, Inc.

IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001228627

In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 7 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.

Holders of 5% or more of IRD

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Opus Genetics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of IRD
HolderLatest formStakeChangeFirst filedLatest filingFiling
Perceptive Advisors LLC13G/A9.99%9.23M shares0.00 ppfrom 9.99%Mar 31, 20254 filingsAug 14, 2026SEC
Caligan Partners LP13G/A7.30%6.08M shares−1.20 ppfrom 8.50%May 15, 20262 filingsAug 14, 2026SEC
Balyasny Asset Management LLC13G/A6.64%5.48M shares−0.54 ppfrom 7.18%Feb 17, 20263 filingsAug 14, 2026SEC
Nantahala Capital Management, LLC13G/A6.51%4.84M shares−3.48 ppfrom 9.99%May 15, 20254 filingsMay 15, 2026SEC
BlackRock, Inc.13G6.10%5.04M sharesNewOct 27, 20261 filingOct 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

31 Schedule 13D and 13G filings on Opus Genetics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IRD
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 12, 20269:03 AM ETAdage Capital Management, L.P.and 2 others13G/A2.71%2.25M shares−5.76 ppfrom 8.47%Below 5%Sep 30, 2026SEC
Oct 27, 20265:25 PM ETBlackRock, Inc.13G6.10%5.04M sharesNewSep 30, 2026SEC
Aug 14, 20265:19 PM ETPerceptive Advisors LLCand 2 others13G/A9.99%9.23M shares0.00 ppfrom 9.99%Jun 30, 2026SEC
Aug 14, 20264:32 PM ETCaligan Partners LPand 1 other13G/A7.30%6.08M shares−1.20 ppfrom 8.50%Jun 30, 2026SEC
Aug 14, 20266:03 AM ETBalyasny Asset Management LLCand 4 others13G/A6.64%5.48M shares−0.54 ppfrom 7.18%Jun 30, 2026SEC
May 20, 20267:53 PM ETFoundation Fighting Blindness Retinal Degeneration Fundand 1 other13D/A4.66%3.79M shares−3.34 ppfrom 8.00%Below 5%May 18, 2026SEC
May 15, 20264:40 PM ETNantahala Capital Management, LLCand 2 others13G/A6.51%4.84M shares−3.48 ppfrom 9.99%Mar 31, 2026SEC
May 15, 20264:00 PM ETPerceptive Advisors LLCand 2 others13G/A9.99%8.83M shares0.00 ppfrom 9.99%Mar 31, 2026SEC
May 15, 202610:56 AM ETCaligan Partners LPand 1 other13G8.50%6.08M sharesNewMar 31, 2026SEC
May 15, 20266:38 AM ETBalyasny Asset Management LLCand 4 others13G/A7.18%5.11M shares−0.23 ppfrom 7.41%Mar 31, 2026SEC
May 13, 202611:07 AM ETBIOS Fund III, LPand 9 others13G/A4.53%3.68M shares−1.67 ppfrom 6.20%Below 5%May 12, 2026SEC
May 13, 20269:44 AM ETAdage Capital Management, L.P.and 2 others13G8.47%6.03M sharesNewMar 31, 2026SEC
Feb 17, 20264:00 PM ETPerceptive Advisors LLCand 2 others13G/A9.99%7.17M shares0.00 ppfrom 9.99%Dec 31, 2025SEC
Feb 17, 20266:28 AM ETBalyasny Asset Management LLCand 4 others13G7.41%5.11M sharesNewDec 31, 2025SEC
Feb 13, 20265:06 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%7.12M shares0.00 ppfrom 9.99%Dec 31, 2025SEC
Dec 11, 20258:52 PM ETFoundation Fighting Blindness Retinal Degeneration Fundand 1 other13D/A8.00%5.49M shares−7.90 ppfrom 15.90%Dec 9, 2025SEC
Aug 14, 20254:32 PM ETNantahala Capital Management, LLCand 2 others13G/A9.99%6.25M shares0.00 ppfrom 9.99%Jun 30, 2025SEC
Aug 11, 20256:56 PM ETBIOS Fund III, LPand 9 others13G6.20%3.68M sharesNewMay 5, 2025SEC
May 15, 20254:33 PM ETNantahala Capital Management, LLCand 2 others13G9.99%4.70M sharesNewMar 31, 2025SEC
May 6, 20255:55 PM ETFoundation Fighting Blindness Retinal Degeneration Fundand 1 other13D/A15.90%9.49M shares–Apr 30, 2025SEC
Mar 31, 20254:10 PM ETPerceptive Advisors LLCand 2 others13G9.99%4.51M sharesNewMar 24, 2025SEC
Oct 29, 2024Foundation Fighting Blindness Retinal Degeneration Fund13DOld format–New–SEC
Feb 14, 2023Sooch Mina13G/AOld format–––SEC
May 17, 2022Richmond Brothers, Inc.13GOld format–New–SEC
Feb 14, 2022Altium Capital Management LP13G/AOld format–––SEC
Feb 14, 2022Sooch Mina13G/AOld format–––SEC
Jan 18, 2022Empery Asset Management, LP13G/AOld format–––SEC
Mar 26, 2021Apexian Pharmaceuticals, Inc.13GOld format–New–SEC
Mar 17, 2021Sooch Mina13GOld format–New–SEC
Feb 16, 2021Altium Capital Management LP13G/AOld format–––SEC
Feb 2, 2021Empery Asset Management, LP13G/AOld format–––SEC

Form 144: proposed insider sales

15 notices from officers, directors and other affiliates planning to sell Opus Genetics, Inc. shares, newest first.

Form 144 notices for IRD
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Nov 3, 20263:50 PM ETMagrath GeorgeOfficer28.3K$110.2KNov 3, 2026Raymond James & Associates, Inc.SEC
Oct 23, 20264:57 PM ETYerxa Benjamin ROfficer33.2K$117.4KOct 23, 2026Raymond James & Associates, Inc.SEC
Oct 23, 20264:04 PM ETGagnon Robert E.Officer14.0K$56.1KOct 23, 202610b5-1Jefferies LLCSEC
Oct 23, 20262:48 PM ETMagrath GeorgeOfficer9.59K$34.4KOct 23, 2026Raymond James & Associates, Inc.SEC
Sep 3, 20264:11 PM ETGagnon Robert E.Officer28.0K$124.6KSep 3, 202610b5-1Jefferies LLCSEC
Jul 23, 20265:21 PM ETGagnon Robert E.Officer7.78K$23.7KJul 23, 2026Jefferies LLCSEC
Jul 23, 20265:17 PM ETMagrath GeorgeOfficer9.47K$28.9KJul 23, 2026Jefferies LLCSEC
Jul 23, 20261:09 PM ETSchachle Joseph KOfficer4.64K$13.7KJul 23, 2026Raymond James & AssociatesSEC
Jul 23, 202612:46 PM ETYerxa Benjamin ROfficer7.43K$22.1KJul 23, 2026Raymond James & AssociatesSEC
Apr 23, 20266:11 PM ETSchachle Joseph KOfficer4.70K$24.5KApr 23, 2026Raymond James & AssociatesSEC
Apr 23, 20265:55 PM ETYerxa Benjamin ROfficer7.47K$39.1KApr 23, 2026Raymond James & AssociatesSEC
Apr 23, 20264:36 PM ETMagrath GeorgeOfficer9.51K$127.3KApr 23, 2026Raymond James & AssociatesSEC
Apr 23, 20264:08 PM ETGagnon Robert E.Officer7.84K$40.7KApr 23, 2026Raymond James & AssociatesSEC
Apr 23, 20263:49 PM ETJayagopal AshwathOfficer7.54K$39.2KApr 23, 2026Raymond James & AssociatesSEC
Mar 16, 20264:54 PM ETMagrath GeorgeOfficer24.4K$127.3KMar 16, 2026Raymond James & AssociatesSEC